This publication describes the recent trends of drug overdose deaths in the United States (U.S.) and the benefits of adopting harm reduction approaches.
Resources and Tools
This guide offers considerations for how state agency staff can develop and maintain an accessible, HIV and opioid use disorder (OUD) service inventory. This guide can be used by state agency HIV and OUD staff to:
This package is a learning tool designed for health departments and community-based organizations newly offering syringe services programs (SSPs) with the purpose of indexing the materials needed for safer injection, what to offer at a syringe services program, and how to explain what materials a
Transgender people and communities, including nonbinary people, have specific needs within harm reduction programs.
This document provides a quick overview of the federal discretionary funding programs that support essential aspects of the nation’s HIV response.
The HIV and OUD Service and Funding Matrices Template supports state health departments in identifying opportunities for enhanced coordination between HIV and OUD funding and service provision.
Achieving the goals of the Ending the HIV Epidemic (EHE) Initiative depends on doing more to strengthen communities, reduce the harm associated with drug use, and prevent disease transmission.
Because of naloxone’s ability to reverse opioid overdose and its ease of use, by July 15, 2017, all 50 states and the District of Columbia had passed legislation to improve naloxone access, as one strategy to reduce opioid overdose morbidity and mortality.
This policy brief identified states potentially at risk for an HIV or HCV outbreak and used data from multiple sources to examine rural-urban differences in 1) state-level infectious disease surveillance, prevention activities, and collaboration with stakeholders; 2) local health department-level